BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Neoleukin Therapeutics Announces First Quarter 2020 Financial Results and Provides Business Update

  Neoleukin Therapeutics, Inc., a biopharmaceutical company utilizing sophisticated computational methods to design de novo protein therapeutics, announced financial results for the first quarter ending March 31, 2020 and provided a business update.

  May 6, 2020

   · 

  4 min read
• Business

  Aravive Reports First Quarter 2020 Financial Results and Provides Recent Corporate Updates

  AVB-500 Phase 1b dose escalation ongoing at 20 mg/kg dose in platinum resistant ovarian cancer with potential for topline data in mid-2020

  May 6, 2020

   · 

  7 min read
• Business

  VIVUS Reports First Quarter 2020 Financial Results

  VIVUS, Inc., a biopharmaceutical company, reported financial results for the quarter ended March 31, 2020 and provided a business update.

  May 6, 2020

   · 

  18 min read
• Business

  Pacific Biosciences of California, Inc. Announces First Quarter 2020 Financial Results

  Pacific Biosciences of California, Inc. announced financial results for its first quarter ended March 31, 2020.

  May 6, 2020

   · 

  6 min read
• Business

  MannKind Corporation Reports 2020 First Quarter Financial Results

  MannKind Corporation reported financial results for the quarter ended March 31, 2020.

  May 6, 2020

   · 

  8 min read
• Biotech Bay

  Codexis Achieves Technology Transfer Milestone with Global Pharmaceutical Leader

  Codexis, Inc., a leading protein engineering company and developer of novel biotherapeutics, announces achievement of the Wave 2 milestone associated with the CodeEvolver® platform technology transfer and license agreement with Novartis Pharma AG that was executed in May, 2019.

  May 6, 2020

   · 

  2 min read
• Business

  Harpoon Therapeutics Reports First Quarter 2020 Financial Results and Provides Corporate Update

  Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company developing a novel class of T cell engagers, reported financial results for the first quarter ended March 31, 2020 and provided a corporate update.

  May 6, 2020

   · 

  8 min read
• Business

  Immunomedics Reports First Quarter 2020 Results and Provides Corporate Update

  Immunomedics, Inc. reported financial results for the first quarter of 2020.

  May 6, 2020

   · 

  13 min read
• Business

  Cytokinetics Reports First Quarter 2020 Financial Results

  Cytokinetics, Incorporated reported financial results for the first quarter of 2020.

  May 6, 2020

   · 

  14 min read
• Business

  MyoKardia Reports First Quarter 2020 Financial Results

  MyoKardia, Inc., reported financial results for the first quarter ended March 31, 2020.

  May 6, 2020

   · 

  8 min read